Researcher profile

Tobias Hatt

Tobias Hatt contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 17 - UnverifiedVerification L1Unclaimed author
4works
0followers
4topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

4 published item(s)

preprint2022arXiv

Combining Observational and Randomized Data for Estimating Heterogeneous Treatment Effects

Estimating heterogeneous treatment effects is an important problem across many domains. In order to accurately estimate such treatment effects, one typically relies on data from observational studies or randomized experiments. Currently, most existing works rely exclusively on observational data, which is often confounded and, hence, yields biased estimates. While observational data is confounded, randomized data is unconfounded, but its sample size is usually too small to learn heterogeneous treatment effects. In this paper, we propose to estimate heterogeneous treatment effects by combining large amounts of observational data and small amounts of randomized data via representation learning. In particular, we introduce a two-step framework: first, we use observational data to learn a shared structure (in form of a representation); and then, we use randomized data to learn the data-specific structures. We analyze the finite sample properties of our framework and compare them to several natural baselines. As such, we derive conditions for when combining observational and randomized data is beneficial, and for when it is not. Based on this, we introduce a sample-efficient algorithm, called CorNet. We use extensive simulation studies to verify the theoretical properties of CorNet and multiple real-world datasets to demonstrate our method's superiority compared to existing methods.

preprint2022arXiv

Detecting User Exits from Online Behavior: A Duration-Dependent Latent State Model

In order to steer e-commerce users towards making a purchase, marketers rely upon predictions of when users exit without purchasing. Previously, such predictions were based upon hidden Markov models (HMMs) due to their ability of modeling latent shopping phases with different user intents. In this work, we develop a duration-dependent hidden Markov model. In contrast to traditional HMMs, it explicitly models the duration of latent states and thereby allows states to become "sticky". The proposed model is superior to prior HMMs in detecting user exits: out of 100 user exits without purchase, it correctly identifies an additional 18. This helps marketers in better managing the online behavior of e-commerce customers. The reason for the superior performance of our model is the duration dependence, which allows our model to recover latent states that are characterized by a distorted sense of time. We finally provide a theoretical explanation for this, which builds upon the concept of "flow".

preprint2022arXiv

Sequential Deconfounding for Causal Inference with Unobserved Confounders

Using observational data to estimate the effect of a treatment is a powerful tool for decision-making when randomized experiments are infeasible or costly. However, observational data often yields biased estimates of treatment effects, since treatment assignment can be confounded by unobserved variables. A remedy is offered by deconfounding methods that adjust for such unobserved confounders. In this paper, we develop the Sequential Deconfounder, a method that enables estimating individualized treatment effects over time in presence of unobserved confounders. This is the first deconfounding method that can be used in a general sequential setting (i.e., with one or more treatments assigned at each timestep). The Sequential Deconfounder uses a novel Gaussian process latent variable model to infer substitutes for the unobserved confounders, which are then used in conjunction with an outcome model to estimate treatment effects over time. We prove that using our method yields unbiased estimates of individualized treatment responses over time. Using simulated and real medical data, we demonstrate the efficacy of our method in deconfounding the estimation of treatment responses over time.

preprint2021arXiv

AttDMM: An Attentive Deep Markov Model for Risk Scoring in Intensive Care Units

Clinical practice in intensive care units (ICUs) requires early warnings when a patient's condition is about to deteriorate so that preventive measures can be undertaken. To this end, prediction algorithms have been developed that estimate the risk of mortality in ICUs. In this work, we propose a novel generative deep probabilistic model for real-time risk scoring in ICUs. Specifically, we develop an attentive deep Markov model called AttDMM. To the best of our knowledge, AttDMM is the first ICU prediction model that jointly learns both long-term disease dynamics (via attention) and different disease states in health trajectory (via a latent variable model). Our evaluations were based on an established baseline dataset (MIMIC-III) with 53,423 ICU stays. The results confirm that compared to state-of-the-art baselines, our AttDMM was superior: AttDMM achieved an area under the receiver operating characteristic curve (AUROC) of 0.876, which yielded an improvement over the state-of-the-art method by 2.2%. In addition, the risk score from the AttDMM provided warnings several hours earlier. Thereby, our model shows a path towards identifying patients at risk so that health practitioners can intervene early and save patient lives.